BiomX, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Stockholders Equity (Details) - Part-2

Stockholders Equity (Details) - Part-2 $ / shares in Units, $ in Thousands									12 Months Ended
	Oct. 29, 2023 USD ($) $ / shares shares	Oct. 19, 2023 $ / shares shares	Aug. 21, 2023 $ / shares shares	Mar. 01, 2023 $ / shares shares	Sep. 30, 2022 $ / shares shares	Aug. 22, 2022 $ / shares shares	Jun. 21, 2022 $ / shares shares	Mar. 29, 2022 $ / shares shares	Dec. 31, 2023 USD ($) $ / shares shares	Jan. 01, 2024 shares	Dec. 11, 2023 $ / shares shares	Feb. 27, 2023 $ / shares	Dec. 31, 2022	Dec. 31, 2019 shares
Stockholders Equity [Line Items]
Warrant expire term									5 years
Warrant redeem price per share (in Dollars per share)									$ 0.01
Common stock equal or exceeds price per share (in Dollars per share)									$ 16
Number of trading days									30 years
Granted shares \| shares										1,839,187				1,000
Outstanding share percentage													4.00%
Issuance of common stock \| shares									1,011,104
Granted option shares \| shares	151,100	41,000	82,000
Vesting period term	4 years	4 years			1 year	4 years	4 years	4 years	1 year 7 months 24 days
Stock option exercise price (in Dollars per share)	$ 0.275	$ 0.32									$ 0.275
Exercise price (in Dollars per share)	0.275											$ 0.001
Original exercise price (in Dollars per share)	$ 0.69
Option exercised period	1 year
Fair value vested amount (in Dollars) \| $	$ 167
Aggregate shares \| shares											1,508,280
2019 Plan [Member]
Stockholders Equity [Line Items]
Granted option shares \| shares				1,543,000	20,000	290,000	350,500	1,153,500
Exercise price (in Dollars per share)					$ 0.37	$ 0.66	$ 0.66	$ 1.41
Aggregate shares \| shares											694,871
Minimum [Member]
Stockholders Equity [Line Items]
Number of trading days									20 years
Vesting period term									3 years
Stock option exchange ratio	1.4
Maximum [Member]
Stockholders Equity [Line Items]
Number of trading days									30 years
Vesting period term									4 years
Stock option exchange ratio	3.8
Stock Options [Member]
Stockholders Equity [Line Items]
Stock option exercise price (in Dollars per share)			$ 0.363
Board of Directors [Member]
Stockholders Equity [Line Items]
Exercise price (in Dollars per share)				$ 0.4
Vesting period term			4 years	4 years
Stock Option [Member]
Stockholders Equity [Line Items]
Stock based compensation (in Dollars) \| $									$ 19